Cardiff Oncology Inc. (CRDF)
NASDAQ: CRDF
· Real-Time Price · USD
2.44
0.00 (0.00%)
At close: Aug 15, 2025, 12:37 PM
Cardiff Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 109K | 151K | 165K | 163K | 205K | 156K | 141K | 108K | 83K | 128K | 93K | 91K | 74K | 133K | 86K | 68K | 72K |
Cost of Revenue | n/a | n/a | 96K | n/a | 105K | 102K | 103K | 107K | 98K | 90K | 50K | 81K | 38K | 31K | 162K | 4.15M | 4.12M | 3.28M |
Gross Profit | n/a | 109K | 55K | 165K | 58K | 103K | 53K | 34K | 10K | -7K | 78K | 12K | 53K | 43K | -29K | -4.07M | -4.05M | -3.21M |
Operating Income | -14.78M | -14.38M | -12.57M | -12.6M | -12.54M | -10.93M | -10.33M | -10.82M | -12.21M | -12.05M | -9.39M | -8.99M | -10.44M | -11.07M | -9.53M | -7M | -6.89M | -5.44M |
Interest Income | n/a | 941K | 787K | 741K | 805K | 926K | 1.01M | 1.07M | 1.05M | 940K | 740K | 458K | 253K | 130K | 136K | 70K | 71K | 57K |
Pretax Income | -13.95M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M | -11.22M | -8.7M | -8.57M | -10.44M | -10.99M | -9.44M | -6.91M | -6.76M | -5.18M |
Net Income | -13.95M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M | -10.39M | -8M | -8.15M | -10.19M | -10.91M | -9.44M | -6.91M | -6.76M | -5.18M |
Selling & General & Admin | 3.32M | 4.01M | 3.01M | 3.13M | 3.21M | 3.03M | 2.73M | 2.94M | 4.3M | 3.08M | 3.08M | 3.08M | 3.09M | 3.94M | 3.83M | 2.93M | 2.84M | 2.23M |
Research & Development | 11.58M | 10.48M | 9.71M | 9.64M | 9.49M | 8.01M | 7.76M | 8.02M | 8.02M | 9.05M | 6.44M | 6.01M | 7.45M | 7.21M | 5.82M | 4.15M | 4.12M | 3.28M |
Other Expenses | n/a | n/a | n/a | n/a | -38K | -4K | -13K | 21K | 5K | -111K | -45K | -36K | n/a | -49K | n/a | 3K | n/a | -1K |
Operating Expenses | 14.9M | 14.49M | 12.72M | 12.77M | 12.6M | 11.04M | 10.38M | 10.96M | 12.32M | 12.13M | 9.52M | 9.09M | 10.53M | 11.15M | 9.66M | 7.08M | 6.96M | 5.51M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 79K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -757K | 400K | 459K | -102K | -1.71M | 536K | 584K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 14.49M | 12.72M | 12.77M | 12.71M | 11.14M | 10.49M | 10.96M | 12.32M | 12.13M | 9.52M | 9.09M | 10.53M | 11.15M | 9.66M | 7.08M | 6.96M | 5.51M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 58.72K | n/a | n/a | n/a | -829K | -695K | -422K | -253K | -81K | 79K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 66.53M | 66.52M | 47.65M | 46.87M | 44.83M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 43.33M | 43.31M | 43.23M | 40.59M | 39.55M | 38.76M | 37.16M |
Shares Outstanding (Diluted) | 66.53M | 47.65M | 47.65M | 46.87M | 44.83M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 43.33M | 43.31M | 43.23M | 40.6M | 39.55M | 38.76M | 37.16M |
EPS (Basic) | -0.21 | -0.2 | -0.25 | -0.25 | -0.26 | -0.22 | -0.21 | -0.22 | -0.25 | -0.23 | -0.18 | -0.19 | -0.24 | -0.25 | -0.23 | -0.17 | -0.17 | -0.14 |
EPS (Diluted) | -0.21 | -0.28 | -0.25 | -0.25 | -0.26 | -0.22 | -0.21 | -0.22 | -0.25 | -0.23 | -0.18 | -0.19 | -0.24 | -0.25 | -0.23 | -0.17 | -0.17 | -0.14 |
EBITDA | -14.78M | -14.15M | -12.48M | -12.5M | -12.44M | -10.83M | -10.23M | -10.71M | -12.11M | -11.96M | -9.31M | -8.91M | -10.4M | -11.04M | -9.28M | -6.89M | -6.78M | -5.32M |
EBIT | n/a | -14.38M | -12.57M | -12.6M | -12.54M | -10.93M | -10.33M | -10.82M | -12.21M | -12.05M | -9.39M | -8.99M | -10.44M | -11.07M | -8.96M | -7M | -6.89M | -5.44M |
Depreciation & Amortization | n/a | 228K | 96K | 101K | 105K | 102K | 103K | 107K | 98K | 90K | 50K | 81K | 38K | 31K | 162K | 110K | 109K | 119K |